Management of Maternal Hypothyroidism in Pregnancy: A Danish Regional Study
Clinical Endocrinology · 2025
DOI: 10.1111/cen.15259 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Endocrinology, 2025. Verfasst von Karoline Schack und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark. Hauptthemen laut MEDLINE: Hypothyroidism, Thyroxine, Pregnancy Complications. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: This study was supported by the Novo Nordisk Foundation (grant number NNF20OC0059465)., Novo Nordisk Fonden.
Abstract (Originalsprache)
Objective
Hypothyroidism in pregnant women must be carefully managed to prevent complications. The aim of this study was to evaluate compliance with clinical recommendations for the monitoring and treatment of hypothyroidism in pregnant women and to assess the clinical action upon each biochemical monitoring at different time points in pregnancy.
Design
Retrospective cohort study.
Participants
Pregnant women with known hypothyroidism in the North Denmark Region, 2022–2024, who were managed in the Departments of Endocrinology.
Measurements
Medical records were reviewed for information on biochemical monitoring of thyroid‐stimulating hormone (TSH) and Levothyroxine (L‐T4) treatment in the pregnancy. The primary study endpoint was the frequency of biochemical monitoring and dose adjustments of L‐T4.
Results
Altogether 175 pregnant women with hypothyroidism treated with L‐T4 before the pregnancy were studied. Biochemical monitoring of TSH in the pregnancy was performed one to 12 times (median 7 times). When considered until and including the 12th week of pregnancy, the number of women with dose adjustment following biochemical control was 84 of 166 (50.6% (95% CI: 42.7%–58.4%)), whereas from the 13th to 24th week it was 35 of 164 (21.3% (95% CI: 15.3%–28.4%)), and from the 25th week of pregnancy and onwards it was 17 of 165 (10.3% (95% CI: 6.1%–16.0%)).
Conclusion
In a Danish regional cohort of pregnant women with hypothyroidism, biochemical monitoring of thyroid function was often performed and was mostly followed by a change in the dose of L‐T4 in early pregnancy ( ~ 50% of the women) and rarely in late pregnancy ( ~ 10% of the women).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark.
- Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
- Department of Endocrinology, Aalborg University Hospital, Aalborg, Denmark.
Förderung
- This study was supported by the Novo Nordisk Foundation (grant number NNF20OC0059465).
- Novo Nordisk Fonden
Zitieren
APA
Schack, K., Laustsen, L. M., Sørensen, R. Z., Lundgaard, M. H., Torp, N. M. U., Karmisholt, J., & Andersen, S. L. (2025). Management of Maternal Hypothyroidism in Pregnancy: A Danish Regional Study. Clinical Endocrinology. https://doi.org/10.1111/cen.15259
Vancouver
Schack K, Laustsen LM, Sørensen RZ, Lundgaard MH, Torp NMU, Karmisholt J, et al. Management of Maternal Hypothyroidism in Pregnancy: A Danish Regional Study. Clinical Endocrinology. 2025. doi:10.1111/cen.15259
BibTeX
@article{Schack2025,
author = {Schack, Karoline and Laustsen, Line Meyer and Sørensen, Randi Ziska and Lundgaard, Maja Hjelm and Torp, Nanna Maria Uldall and Karmisholt, Jesper and Andersen, Stine Linding},
title = {Management of Maternal Hypothyroidism in Pregnancy: A Danish Regional Study},
journal = {Clinical Endocrinology},
year = {2025},
doi = {10.1111/cen.15259}
}
EUVIMED